Prevalence of Psoriasis Alba in Psoriatic Patients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00835315
First received: February 1, 2009
Last updated: August 11, 2010
Last verified: February 2009

February 1, 2009
August 11, 2010
January 2008
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00835315 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prevalence of Psoriasis Alba in Psoriatic Patients
Not Provided

Interdigital psoriasis (psoriasis alba) is atypical and rare form of psoriasis that is often missed as it is commonly mistaken for either dermatoses or fungal infection.In this study we observed and analyzed the prevalence of psoriasis interdigital of palms and soles and brought medical awareness to dermatologists and family doctors this rare form of psoriasis. Thus, you can help to avoid mistaken diagnosis and the start of correct treatment as soon as possible.

Hospitalized patients and outpatient clinic will be included in the study after receiving the signature of a inform consent.Patients groups : 100 patients with psoriasis,100 patients with atopic dermatitis and 100 healthy patients (control group).Patients with atopic dermatitis will be the secondary control group.Patients diagnosed with inflammatory condition of interdigital skin of the palms and soles will be checked by fungal microscopy test.If the fungal test is negative ,we need to prepare to a biopsy of the skin in this area .Following results of the skin biopsy conclusions can be shown about the prevalence of interdigital psoriasis in psoriatic patients enabling suitable treatment to be given to the patients.

Observational
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample

patients of dermatology depatment and outpatient clinic in the hospital

Psoriasis
Not Provided
3
patients with psoriasis , patients with atopic dermatitis and healthy patients.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Enrolling by invitation
300
Not Provided
Not Provided

Inclusion Criteria:

  • patients above 18 years old ,hebrew speakers, patients with psoriasis vulgaris or atopic dermatitis without systemic treatment

Exclusion Criteria:

  • patients below 18 years old, pregnancy women, patients treated with systemic agents for psoriasis or atopic dermatitis(methotrexate,cyclosporin,neotigason)
Both
18 Years and older
Yes
Contact information is only displayed when the study is recruiting subjects
Not Provided
 
NCT00835315
IPS001-HMO-CTIL
Yes
hadassa medical organization,jerusalem,israel, hadassah medical organization
Hadassah Medical Organization
Not Provided
Principal Investigator: Vera Leibovici, MD Hadassah Medical Organization
Principal Investigator: Natalya Lemster, MD Hadassah Medical Organization
Hadassah Medical Organization
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP